PT Mobile Logo

Search form


Eric Hollander, MD

Eric Hollander, MD

Posts by Author

Proposed changes in the conceptualization of compulsivity and impulsivity in the DSM-V will have important implications in the way clinicians recognize and treat these disabling conditions.

Although there is no pharmacological agent that has been approved by the U.S. Food and Drug Administration for the treatment of autism, new studies are showing promise in not only discovering the cause of autism, but pharmacological treatments as well.

By clicking Accept, you agree to become a member of the UBM Medica Community.